Sylvain Lehoux

Sylvain Lehoux

Auto-generated profile, based on publicly available information

Sylvain Lehoux

Harvard Medical School Center for Glycoscience, Harvard Medical School, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RMRobert G. Mealer
Robert G. Mealer
BJBruce G. Jenkins
Bruce G. Jenkins
CCChia-Yen Chen
Chia-Yen Chen
MDMark J. Daly
Mark J. Daly
TGTian Ge
Tian Ge
JSJordan Smoller
Jordan Smoller
A common missense variant in SLC39A8 is convincingly associated with schizophrenia and several additional phenotypes. Homozygous loss-of-function mutations in SLC39A8 result in undetectable serum manganese (Mn) and a Congenital Disorder of Glycosylation (CDG) due to the exquisite sensitivity of glycosyltransferases to Mn concentration. Here, we identified several Mn-related changes in human carriers of the common SLC39A8 missense allele. Analysis of structural brain MRI scans showed a dose-dependent change in the ratio of T2w to T1w signal in several regions. Comprehensive trace element analysis confirmed a specific reduction of only serum Mn, and plasma protein N-glycome profiling revealed reduced complexity and branching. N-glycome profiling from two individuals with SLC39A8-CDG showed similar but more severe alterations in branching that improved with Mn supplementation, suggesting that the common variant exists on a spectrum of hypofunction with potential for reversibility. Characterizing the functional impact of this variant will enhance our understanding of schizophrenia pathogenesis and identify novel therapeutic targets and biomarkers.

10 May 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
RBRhea Bhargava
Rhea Bhargava
SLSylvain Lehoux
Sylvain Lehoux
KMKayaho Maeda
Kayaho Maeda
GTGeorge Tsokos
George Tsokos
SKSuzanne Krishfield
Suzanne Krishfield
GTGeorge Tsokos
George Tsokos
Lupus nephritis (LN) is a serious complication occurring in 50% of patients with systemic lupus erythematosus (SLE) for which there is a lack of biomarkers, a lack of specific medications, and a lack of a clear understanding of its pathogenesis. The expression of calcium/calmodulin kinase IV (CaMK4) is increased in podocytes of patients with LN and lupus-prone mice, and its podocyte-targeted inhibition averts the development of nephritis in mice. Nephrin is a key podocyte molecule essential for the maintenance of the glomerular slit diaphragm. Here, we show that the presence of fucose on N-glycans of IgG induces, whereas the presence of galactose ameliorates, podocyte injury through CaMK4 expression. Mechanistically, CaMK4 phosphorylates NF-κB, upregulates the transcriptional repressor SNAIL, and limits the expression of nephrin. In addition, we demonstrate that increased expression of CaMK4 in biopsy specimens and in urine podocytes from people with LN is linked to active kidney disease. Our data shed light on the role of IgG glycosylation in the development of podocyte injury and propose the development of “liquid kidney biopsy” approaches to diagnose LN.

10 August 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JZJunwei Zeng
Junwei Zeng
MEMahmoud Eljalby
Mahmoud Eljalby
RARajindra Aryal
Rajindra Aryal
SLSylvain Lehoux
Sylvain Lehoux
KSKathrin Stavenhagen
Kathrin Stavenhagen
Richard D. CummingsRichard D. Cummings
Richard D. Cummings
The molecular mechanisms regulating lymphocyte homing into lymph nodes are only partly understood. Here, we report that B cell-specific deletion of the X-linked gene,Cosmc, and the consequent decrease of protein O-glycosylation, induces developmental blocks of mouse B cells. After transfer into wild-type recipient,Cosmc-null B cells fail to home to lymph nodes as well as non-lymphoid organs. Enzymatic desialylation of wild-type B cells blocks their migration into lymph nodes, indicating a requirement of sialylated O-glycans for proper trafficking. Mechanistically,Cosmc-deficient B cells have normal rolling and firm arrest on high endothelium venules (HEV), thereby attributing their inefficient trafficking to alterations in the subsequent transendothelial migration step. Finally,Cosmc-null B cells have defective chemokine signaling responses. Our results thus demonstrate thatCosmcand its effects on O-glycosylation are important for controlling B cell homing.

11 May 2018 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
KKKristi A. Koelsch
Kristi A. Koelsch
JCJoshua Cavett
Joshua Cavett
KSKenneth Smith
Kenneth Smith
JMJacen S. Moore
Jacen S. Moore
SLSylvain D. Lehoux
Sylvain D. Lehoux
RSR Hal Scofield
R Hal Scofield
Objective: To better understand the role of B cells, the potential mechanisms responsible for their aberrant activation, and the production of autoantibodies in the pathogenesis of Sjögren's syndrome (SS), this study explored patterns of selection pressure and sites of N‐glycosylation acquired by somatic mutation (acN‐glyc) in the IgG variable (V) regions of antibody‐secreting cells (ASCs) isolated from the minor salivary glands of patients with SS and non‐SS control patients with sicca symptoms.Methods: A novel method to produce and characterize recombinant monoclonal antibodies (mAb) from single cell–sorted ASC infiltrates was applied to concurrently probe expressed genes (all heavy‐ and light‐chain isotypes as well as any other gene of interest not related to immunoglobulin) in the labial salivary glands of patients with SS and non‐SS controls. V regions were amplified by reverse transcription–polymerase chain reaction, sequenced, and analyzed for the incidence of N‐glycosylation and selection pressure. For specificity testing, the amplified regions were expressed as either the native mAb or mutant mAb lacking the acN‐glyc motif. Protein modeling was used to demonstrate how even an acN‐glyc site outside of the complementarity‐determining region could participate in, or inhibit, antigen binding.Results: V‐region sequence analyses revealed clonal expansions and evidence of secondary light‐chain editing and allelic inclusion, of which neither of the latter two have previously been reported in patients with SS. Increased frequencies of acN‐glyc were found in the sequences from patients with SS, and these acN‐glyc regions were associated with an increased number of replacement mutations and lowered selection pressure. A clonal set of polyreactive mAb with differential framework region 1 acN‐glyc motifs was also identified, and removal of the acN‐glyc could nearly abolish binding to autoantigens.Conclusion: These findings support the notion of an alternative mechanism for the selection and proliferation of some autoreactive B cells, involving V‐region N‐glycosylation, in patients with SS.

7 July 2022 in Genes
Verified
Journal Article
Open access
PDF file
JMJarrod Moore
Jarrod Moore
RHRyan Hekman
Ryan Hekman
BBBenjamin C. Blum
Benjamin C. Blum
MLMatthew Luke Lawton
Matthew Luke Lawton
SLSylvain Lehoux
Sylvain Lehoux
AQAlia Qureshi
Alia Qureshi
(1) Background: Barrett’s esophagus is a major risk factor for esophageal adenocarcinoma. In this pilot study, we employed precision mass spectrometry to map global (phospho)protein perturbations in Barrett’s esophagus lesions and adjacent normal tissue to glean insights into disease progression. (2) Methods: Biopsies were collected from two small but independent cohorts. Comparative analyses were performed between Barrett’s esophagus samples and adjacent matched (normal) tissues from patients with known pathology, while specimens from healthy patients served as additional controls. (3) Results: We identified and quantified 6810 proteins and 6395 phosphosites in the discovery cohort, revealing hundreds of statistically significant differences in protein abundances and phosphorylation states. We identified a robust proteomic signature that accurately classified the disease status of samples from the independent patient cohorts. Pathway-level analysis of the phosphoproteomic profiles revealed the dysregulation of specific cellular processes, including DNA repair, in Barrett’s esophagus relative to paired controls. Comparative analysis with previously published transcriptomic profiles provided independent evidence in support of these preliminary findings. (4) Conclusions: This pilot study establishes the feasibility of using unbiased quantitative phosphoproteomics to identify molecular perturbations associated with disease progression in Barrett’s esophagus to define potentially clinically actionable targets warranting further assessment.

1 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SWSarah Williams
Sarah Williams
MNMaxence Noel
Maxence Noel
SLSylvain D Lehoux
Sylvain D Lehoux
MCMurat Cetinbas
Murat Cetinbas
RXRamnik J. Xavier
Ramnik J. Xavier
RMRobert G. Mealer
Robert G. Mealer
Summary: Glycosylation is essential to brain development and function, though prior studies have often been limited to a single analytical technique. Using several methodologies, we analyzed Asn-linked (N-glycans) and Ser/Thr/Tyr-linked (O-glycans) protein glycosylation between brain regions and sexes in mice. Brain N-glycans were surprisingly less complex in sequence and variety compared to other tissues, consisting predominantly of high-mannose precursors and fucosylated/bisected structures. Most brain O-glycans were unbranched, sialylated O-GalNAc and O-mannose structures. A consistent pattern was observed between regions, and sex differences were minimal compared to those observed in plasma. Brain glycans correlate with RNA expression of their synthetic enzymes, and analysis of all glycosylation genes in humans showed a global downregulation in the brain compared to other tissues. We hypothesize that the restricted repertoire of protein glycans arises from their tight regulation in the brain. These results provide a roadmap for future studies of glycosylation in neurodevelopment and disease.